2015 Volume 6 Issue 1 Pages 23-27
Low dose weekly methotrexate(MTX)is one of the most effective drugs in the treatment for juvenile idiopathic arthritis(JIA).The purpose of the present study was to investigate the current state of MTX therapy for JIA ill Japan. A questionnaire was sent to 15 pediatricians including l2 pediatric rheumatologists in Japan. It was the most common method that starting weekly dose was 6mg/m2 and dosage was increased to 10mg/m2 by 2mg/m2 every l - 2 weeks. Folate supplement was variably performed. Abdominal discomfort and nausea were frequently observed. The assessment of efficacy was performed after three months of treatment. The criteria for withdrawal or discontinuation of MTX therapy were variable. These results revealed that there was still a significant variation of MTX treatment among institutes in Japan. Toward the establishment of all appropriate MTX therapy,a national wide population based study is desired.